Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CSL01050G	注射用重组人新型复合α干扰素(122Arg)	Lyophilized	Biological Products(2+5)	New Drug Application	2002-05-09	北京双鹭药业股份有限公司	Beijing SL Pharmaceutical Co Ltd	Certificate Issued	2003-05-09	view
CXSR1000005	注射用重组人新型复合α干扰素(122Arg)	Lyophilized	Biological Products	State Standards	2010-08-25	北京双鹭药业股份有限公司	Beijing SL Pharmaceutical Co Ltd	Certificate Issued	2011-08-03	view
CXSS0600067	注射用重组人新型复合α干扰素（122Arg）	Lyophilized	Biological Products(9)	New Drug Application	2006-10-10	北京双鹭药业股份有限公司	Beijing SL Pharmaceutical Co Ltd;Beijing SLLS Medical Technology Co Ltd	Certificate Issued	2007-09-18	view
CXSS0600068	注射用重组人新型复合α干扰素（122Arg）	Lyophilized	Biological Products(9)	New Drug Application	2006-10-10	北京双鹭药业股份有限公司	Beijing SL Pharmaceutical Co Ltd;Beijing SLLS Medical Technology Co Ltd	Certificate Issued	2007-09-18	view
CXSS0800041	注射用重组人新型复合α干扰素(122Arg)	Lyophilized	Biological Products(9)	New Drug Application	2009-09-02	北京双鹭药业股份有限公司	Beijing SL Pharmaceutical Co Ltd	Certificate Issued	2010-06-18	view